doxepin has been researched along with Acute Confusional Senile Dementia in 2 studies
Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hajjo, R | 1 |
| Setola, V | 1 |
| Roth, BL | 1 |
| Tropsha, A | 1 |
| Higuchi, M | 1 |
| Yanai, K | 1 |
| Okamura, N | 1 |
| Meguro, K | 1 |
| Arai, H | 1 |
| Itoh, M | 1 |
| Iwata, R | 1 |
| Ido, T | 1 |
| Watanabe, T | 1 |
| Sasaki, H | 1 |
2 other studies available for doxepin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Chemocentric informatics approach to drug discovery: identification and experimental validation of selective estrogen receptor modulators as ligands of 5-hydroxytryptamine-6 receptors and as potential cognition enhancers.
Topics: Alzheimer Disease; Cell Line, Tumor; Cloning, Molecular; Cognition; Drug Discovery; Drug Evaluation, | 2012 |
Histamine H(1) receptors in patients with Alzheimer's disease assessed by positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain Chemistry; Carbon Radioisotopes; Cer | 2000 |